Back to News
Nov 5, 2025 4:00 PM

Charles River Beat Expectations But Why Is The Stock Falling?

Charles River Laboratories International Inc. (NYSE:CRL) stock is trading lower on Wednesday after the company released third-quarter 2025 earnings. It also provided an update on the company’s strategic review.

CRL is feeling the pressure from bearish momentum. Get the details here

The life science tools company reported quarterly revenue of $1.01 billion, a 0.5% decrease year-over-year, beating the consensus estimate of $990.77 million.

The impact of foreign currency translation increased reported revenue by 1.3%, and the divestiture of a small Safety Assessment site in 2024 reduced reported revenue by 0.2%. Excluding the effect of these items, revenue declined 1.6% on an organic basis.

Also Read: Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years

Operating margin increased to 13.3% from 11.6%, primarily driven by lower costs associated with the company’s restructuring initiatives. Adjusted operating margin decreased to 19.7% from 19.9%.

Charles River’s adjusted ...